- Home
- Advocacy
- Latest News and Practice Data
- Protecting patient access to diagnostic testing across the US
On top of the efficiency adjustment cuts, Medicare may cut payment to 800 clinical lab tests by up to 15% in 2026.
The impact: These reductions will limit patient access to essential tests and weaken laboratory infrastructure, creating a domino effect in labs nationwide.
- While the short-term continuing resolution delays the cuts through the end of January 2026, this is only a temporary solution.
- Without action on a long-term fix, laboratories will again face deep cuts.
What we're doing: Pathologists are asking Congress to support the RESULTS Act.
- The bill stabilizes the nation’s laboratory infrastructure, stops the harmful Medicare payment cuts, and establishes a modernized payment framework that protects patient access.
The future of diagnostic care is at stake. Speak up now to protect access to timely, life-saving, accurate diagnostic testing.